Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: Phase III study results

Author:

ATIENZA TITO1,AQUINO TERESITA2,FERNÁNDEZ MARCELO3,BOONSAWAT WATCHARA4,KAWAI MITSURU5,KUDO TAKAHIDE6,Ekelund Jan7,Ivanov Stefan7,Carlsson Lars-Goran7

Affiliation:

1. Mary Mediatrix Medical Center; Lipa City; Batangas

2. Veterans Memorial Medical Centre; Quezon City; Philippines

3. Centro Respiratorio Quilmes; Buenos Aires; Argentina

4. Faculty of Medicine; Khon Kaen University; Khon Kaen; Thailand

5. Kawai Chest Clinic; Kyoto

6. AstraZeneca KK; Osaka; Japan

7. AstraZeneca R&D; Molndal; Sweden

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Reference20 articles.

1. Global Initiative for Asthma (GINA) Global strategy for asthma management and prevention 2011 http://www.ginasthma.org

2. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid;Greening;Lancet,1994

3. Low dose inhaled budesonide and formoterol in mild persistent asthma: OPTIMA randomized trial;O'Byrne;Am. J. Respir. Crit. Care Med.,2001

4. Effect of inhaled formoterol and budesonide on exacerbations of asthma;Pauwels;N. Engl. J. Med.,1997

5. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids;Woolcock;Am. J. Respir. Crit. Care Med.,1996

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3